These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 32108526)

  • 1. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice.
    Zhang G; Kang Y; Cathey D; LeBlanc AJ; Cai J; Cai L; Wang S; Huang J; Keller BB
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):425-436. PubMed ID: 35157168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress.
    Pan J; Wang R; Pei Y; Wang D; Wu N; Ji Y; Tang Q; Liu L; Cheng K; Liu Q; Sun J; Gong M; Zheng X; Li J; Zhang C; Yuan Y
    J Nutr Biochem; 2023 Jan; 111():109182. PubMed ID: 36220525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.
    Conzatti A; Colombo R; Siqueira R; Campos-Carraro C; Turck P; Luz de Castro A; Belló-Klein A; Sander da Rosa Araujo A
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):612-620. PubMed ID: 38547510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
    Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
    [No Abstract]   [Full Text] [Related]  

  • 9. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct right ventricle remodeling in response to pressure overload in the rat.
    Mendes-Ferreira P; Santos-Ribeiro D; Adão R; Maia-Rocha C; Mendes-Ferreira M; Sousa-Mendes C; Leite-Moreira AF; Brás-Silva C
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H85-95. PubMed ID: 27199115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.
    Lu M; Chen LY; Gairhe S; Mazer AJ; Anderson SA; Nelson JNH; Noguchi A; Siddique MAH; Dougherty EJ; Zou Y; Johnston KA; Yu ZX; Wang H; Wang S; Sun J; Solomon SB; Vanderpool RR; Solomon MA; Danner RL; Elinoff JM
    Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L315-L332. PubMed ID: 35043674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
    Boehm M; Arnold N; Braithwaite A; Pickworth J; Lu C; Novoyatleva T; Kiely DG; Grimminger F; Ghofrani HA; Weissmann N; Seeger W; Lawrie A; Schermuly RT; Kojonazarov B
    BMC Pulm Med; 2018 Mar; 18(1):41. PubMed ID: 29499691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.
    Bai Y; Chen Q; Sun YP; Wang X; Lv L; Zhang LP; Liu JS; Zhao S; Wang XL
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28636290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.
    Philip JL; Murphy TM; Schreier DA; Stevens S; Tabima DM; Albrecht M; Frump AL; Hacker TA; Lahm T; Chesler NC
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1167-H1177. PubMed ID: 30767670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulforaphane enriched transcriptome of lung mitochondrial energy metabolism and provided pulmonary injury protection via Nrf2 in mice.
    Cho HY; Miller-DeGraff L; Blankenship-Paris T; Wang X; Bell DA; Lih F; Deterding L; Panduri V; Morgan DL; Yamamoto M; Reddy AJ; Talalay P; Kleeberger SR
    Toxicol Appl Pharmacol; 2019 Feb; 364():29-44. PubMed ID: 30529165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.
    Clements RT; Vang A; Fernandez-Nicolas A; Kue NR; Mancini TJ; Morrison AR; Mallem K; McCullough DJ; Choudhary G
    Circ Heart Fail; 2019 Nov; 12(11):e005819. PubMed ID: 31707802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.
    Frump AL; Goss KN; Vayl A; Albrecht M; Fisher A; Tursunova R; Fierst J; Whitson J; Cucci AR; Brown MB; Lahm T
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L873-90. PubMed ID: 25713318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
    Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
    Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.